Literature DB >> 17978862

Sequence conservation between porcine and human LRRK2.

Knud Larsen1, Lone Bruhn Madsen.   

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is a member of the ROCO protein superfamily (Ras of complex proteins (Roc) with a C-terminal Roc domain). Mutations in the LRRK2 gene lead to autosomal dominant Parkinsonism. We have cloned the porcine LRRK2 cDNA in an attempt to characterize conserved and therefore likely functional domains. The LRRK2 cDNA contains an open reading frame of 7,578 bp. The predicted LRRK2 protein consists of 2,526 amino acids of 86-93% identity with its mammalian couterparts. The deduced amino acid sequence of encoded porcine LRRK2 protein displays extensive homology with its human counterpart, with greatest similarities in those regions that contain the kinase domain, the Roc domain and the COR motif. Expression of porcine LRRK2 mRNA in various organs and tissues is similar to its human counterpart and not limited to the brain. The obtained data show that the LRRK2 sequence and expression patterns are conserved across species. The porcine LRRK2 gene was mapped to chromosome 5q25. The results obtained suggest that the LRRK2 gene might be of particular interest in our attempt to generate a transgenic porcine model for Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978862     DOI: 10.1007/s11033-007-9172-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  LRRK2 mutations and Parkinsonism.

Authors:  Mathias Toft; Ignacio F Mata; Jennifer M Kachergus; Owen A Ross; Matthew J Farrer
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

3.  LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century.

Authors:  Suzanne Lesage; Anne-Louise Leutenegger; Pablo Ibanez; Sabine Janin; Ebba Lohmann; Alexandra Dürr; Alexis Brice
Journal:  Am J Hum Genet       Date:  2005-08       Impact factor: 11.025

4.  A somatic cell hybrid panel for pig regional gene mapping characterized by molecular cytogenetics.

Authors:  M Yerle; G Echard; A Robic; A Mairal; C Dubut-Fontana; J Riquet; P Pinton; D Milan; Y Lahbib-Mansais; J Gellin
Journal:  Cytogenet Cell Genet       Date:  1996

5.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Authors:  Jennifer Kachergus; Ignacio F Mata; Mary Hulihan; Julie P Taylor; Sarah Lincoln; Jan Aasly; J Mark Gibson; Owen A Ross; Timothy Lynch; Joseph Wiley; Haydeh Payami; John Nutt; Demetrius M Maraganore; Krzysztof Czyzewski; Maria Styczynska; Zbigniew K Wszolek; Matthew J Farrer; Mathias Toft
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

6.  Distribution of PINK1 and LRRK2 in rat and mouse brain.

Authors:  Jean-Marc Taymans; Chris Van den Haute; Veerle Baekelandt
Journal:  J Neurochem       Date:  2006-06-12       Impact factor: 5.372

7.  Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

Authors:  Wanli W Smith; Zhong Pei; Haibing Jiang; Darren J Moore; Yideng Liang; Andrew B West; Valina L Dawson; Ted M Dawson; Christopher A Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

Review 8.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

9.  The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

Authors:  Patrick A Lewis; Elisa Greggio; Alexandra Beilina; Shushant Jain; Acacia Baker; Mark R Cookson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-10       Impact factor: 3.575

10.  A common LRRK2 mutation in idiopathic Parkinson's disease.

Authors:  William P Gilks; Patrick M Abou-Sleiman; Sonia Gandhi; Shushant Jain; Andrew Singleton; Andrew J Lees; Karen Shaw; Kailash P Bhatia; Vincenzo Bonifati; Niall P Quinn; John Lynch; Daniel G Healy; Janice L Holton; Tamas Revesz; Nicholas W Wood
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

View more
  4 in total

1.  The association of CLOCK gene T3111C polymorphism and hPER3 gene 54-nucleotide repeat polymorphism with Chinese Han people schizophrenics.

Authors:  Jing Zhang; Ga Liao; Chang Liu; Lei Sun; Yanyou Liu; Yuhui Wang; Zhou Jiang; Zhengrong Wang
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

2.  Regulation of LRRK2 expression points to a functional role in human monocyte maturation.

Authors:  Jonathan Thévenet; Rosanna Pescini Gobert; Robertus Hooft van Huijsduijnen; Christoph Wiessner; Yves Jean Sagot
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

3.  Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells.

Authors:  Makoto Kubo; Ryuichi Nagashima; Mitsue Kurihara; Fumitaka Kawakami; Tatsunori Maekawa; Koji Eshima; Etsuro Ohta; Hirotomo Kato; Fumiya Obata
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

4.  Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.

Authors:  Florian Giesert; Andreas Hofmann; Alexander Bürger; Julia Zerle; Karina Kloos; Ulrich Hafen; Luise Ernst; Jingzhong Zhang; Daniela Maria Vogt-Weisenhorn; Wolfgang Wurst
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.